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Abstract
Background: Using standard diagnostic algorithms it is not always possible to establish the correct phenotype of
inflammatory bowel disease which is essential for therapeutical decisions. Endoscopic ultrasound elastography is a
new endoscopic procedure which can differentiate the stiffness of normal and pathological tissue by ultrasound.
Therefore, we aimed to investigate the role of transrectal ultrasound elastography in distiction between Crohn’s
disease and ulcerative colitis.
Methods: A total 30 Crohn’s disease, 25 ulcerative colitis, and 28 non-inflammatory bowel disease controls were
included. Transrectal ultrasound elastography was performed in all patients and controls. In all ulcerative coltis
patients and 80% of Crohn’s disease patients endoscopy was performed to assess disease activity in the rectum.
Results: Significant difference in rectal wall thickness and strain ratio was detected between patients with Crohn’s
disease and controls (p = 0.0001). CD patients with active disease had higher strain ratio than patients in remission
(p = 0.02). In ulcerative colitis group a significant difference in rectal wall thickness was found between controls
and patients with active disease (p = 0.03). A significant difference in rectal wall thickness (p = 0.02) and strain ratio
(p = 0.0001) was detected between Crohn’s disease and ulcerative colitis patient group. Crohn’s disease patients
with active disease had a significantly higher strain ratio compared to ulcerative colitis patients with active disease
(p = 0.0001).
Conclusion: Transrectal ultrasound elastography seems to be a promising new diagnostic tool in the field of
inflammatory bowel disease. Further study on a larger cohort of patients is needed to definitely assess the role of
transrectal ultrasound elastography in inflammatory bowel disease.
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Background
The diagnosis of inflammatory bowel disease (IBD) is
based on clinical, endoscopic, radiologic and histologic
criteria [1]. There are two main IBD phenotypes -
Crohn’s disease (CD) and ulcerative colitis (UC). In
some circumstances, especially when disease extension
is restricted exclusively to colon or in acute, severe
phases of the disease like pancolitis when inflammation
is widely spread to the colon, establishing an accurate
diagnosis is very difficult. Assigning the exact phenotype
of IBD as Crohn’s colitis or UC is essential for guiding
therapy decisions and detecting complications that war-
rant treatment and when IBD is confined to the colon it
is especially important to define final phenotype before
surgical decision.
Endoscopic examination is the mainstay in the diagno-
sis of IBD. Endoscopic appearance (distribution and
shape of lesions) helps to differentiate CD from UC in
most cases. Histology analysis confirms the elements of
chronic inflammation but it is not exclusively diagnostic.
Patients with UC may have atypical histological features
such as microscopic inflammation of the ileum, patchi-
ness, and relative rectal sparing at the time of diagnosis.
These findings should not prompt the clinician to
change the diagnosis from UC to CD. Other endoscopic
findings, such as macroscopic cobblestoning, segmental
colitis, ileal stenosis and ulceration, perianal disease, and
pathologically confirmed multiple granulomas in the * Correspondence: nadan.rustemovic@zg.t-com.hr
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of CD.
Unfortunately, none of the classic or new endoscopic
tools is strictly diagnostic for the exact IBD phenotype.
The clinicians hope that progress being made in genet-
ics, serological markers, and imaging studies will lead to
more reliable determination of exact IBD phenotype [2].
In the meantime it is reasonable to examine all possibili-
ties to find better methods for differentiation between
distinct IBD phenotypes. We think that endoscopic
ultrasound (EUS) elastography is a perspective and pro-
mising method to achieve this goal. It is a new endo-
scopic procedure which can differentiate the stiffness of
normal and pathological tissue by ultrasound. This find-
ing is based on B-mode scanning during compressions
[3]. There are some data on elastography applied on the
GI tract, biliary tract, kidney, muscle, breast and the
heart [3-5]. According to the fact that imaging of ultra-
sound tissue elasticity is a way to distinct characteristics
of tissue we hypothesized that EUS elastography has the
role in assessing the thickness of bowel wal in patients
with IBD. As elastography has a potential to define tis-
sue characteristics we hypothesized that using this
method we can differentiate two forms of inflammation
in colon: Crohn colitis and ulcerative colitis [6,7].
Based on the fact that CD is a transmural disease
while in UC inflammation is limited to the mucosa and
submucoasa we aimed to assess the role of transrectal
ultrasound elastography in distinction between CD and
UC.
Methods
We included a total of 55 patients, 30 with CD and 25
with UC, and 28 non-IBD controls. Diagnosis of CD
and UC was confirmed by clinical, radiologic, endo-
scopic, and histologic criteria. All biopsies of patients
were reviewed by our pathologist who is well-experi-
enced in IBD. Patients in whom there was doubt about
the disease phenotype (unclassified IBD (IBDU))) were
excluded from this study.
Clinical characteristics of CD and UC patients are
given in table 1. As can be seen 46% of included CD
patients had rectal involvement either at endoscopy or
described in previous medical history. In all UC patients
and in 80% of CD patients (24/30) endoscopy was per-
formed to assess disease activity in the rectum. For UC,
disease activity was assessed based on the Baron score
[8]. For CD patients disease activity in the rectum was
graded by the endoscopist based on the endoscopic
appearance as “remission” if no visible lesions were
seen, as “mild activity” if erythematous mucosa and/or
erosions of the mucosa were seen but with no ulcers in
the rectum and as “severe activity” if ulcerations or
spontaneous bleeding were found. In IBD patients
endoscopy was performed after a median of 0.16
months, interquartile range (IQR) [0.03-0.99] months,
from TRUS. In all patients and non-IBD controls trans-
rectal ultrasound (TRUS) elastography was performed.
Linear echo-endoscope (Pentax FG-38 UX) with the
probes of 7, 5-12 MHz (Hitachi EUB 8500) was used for
the investigation. All patients were examined in the left
lateral decubital position, without previous preparation.
The probe was covered with condom and inserted in
the ampulla of the rectum under direct vision. A 170
degree linear probe display of the rectal wall and sur-
rounding tissue was provided. Total wall thickness was
measured. Real time tissue elastography was performed.
Quantification of elastography data was evaluated by the
strain ratio (SR). In order to obtain EUS elastography
strain ratio an elipse was adjusted to the rectal wall, and
second one (same diameter) was adjusted to the sur-
rounding tissue up to 15 mm from the rectal wall where
the elastography signal was most obvious. Strain ratio is
ratio of strain between two regions of interest (ROI) in
the same image. Rectal wall tissue was used as a first
ROI, and perirectal tissue as second (Figure 1 and 2).
The SR (rectal wall tissue strain %/perirectal tissue
strain %) was calculated automaticaly using Hitachi
EUB-8500 software.
SR was measured 3 times in anterior, posterior and
lateral region ofthe rectal wall and surrounding tissues.
Middle value was used in statistical analysis [9]. All
examinations were performed by one observer.
Informed consent was obtained from all patients and
the study was approved by the ethics committee of the
University Hospital Centre Zagreb.
Statistics
Basic group comparisons were performed using SPSS
ver. 15.0 for Windows (SPSS Inc, Chicago, IL). Differ-
ences in continuous variables between IBD patients and
non-IBD controls as well as between CD and UC
patients were tested using independent sample t test
and Mann Whitney U test for normally and not nor-
mally distributed variables respectively. Significance was
accepted at a level of p < 0.05.
Results
A summary of results is given in table 2 and Figures 3
and 4. As can be seen in table 2 a significant difference
in rectal wall thickness between IBD group as a whole
and non IBD controls was found (p = 0.001). We also
detected a trend toward a higher strain ratio in IBD
patients as compared to controls but the difference did
not reach significance. IBD patients were significantly
younger than non-IBD controls when they underwent
TRUS (p = 0.0001). As can be seen in Figure 3 and 4, a
significant difference was found both rectal wall
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to controls (p = 0.0001). Interestingly, even the CD
patients without rectal involvement had a significantly
thicker rectal wall when compared to controls (median
4.65 mm vs 3.6 mm; p = 0.028). In the CD patient
group patients with active disease (n = 14) had a signifi-
cantly higher strain ratio in comparison with patients in
remission (n = 10) (p = 0.02; median 1.37 IQR [1.20-
1.56] vs median 0.97 IQR [0.54-1.20]). No significant
difference in rectal wall thickness was found in patients
with active CD and CD patients in remission. In the UC
group no significant difference was found between UC
patients and non-IBD controls in regards to rectal wall
thickness and strain ratio (Figure 3 and 4). The sub-
group of UC patients with active inflammation in the
rectum on endoscopy had a significantly thicker rectal
wall when compared to controls (median 4.5 mm vs 3.6
mm; p = 0.03). No significant difference in strain ratio
was detected. In the UC patient group no significant dif-
ference in rectal wall thickness and strain ratio was
found between UC patients with active disease (n = 14)
and UC patients in remission (n = 11). Comparing the
group of CD and UC patients we found a significant dif-
ference in age at diagnosis, rectal wall thickness and
strain ratio between the groups with CD patients being
significantly younger at diagnosis (median 23.01 years vs
33.35 years; p = 0.016) and having significantly thicker
rectal wall (median 5.0 mm vs 4.2 mm; p = 0.021) and
higher strain ratio (1.18 vs 0.65; p = 0.0001) in compari-
son with the UC patient group. No significant difference
in age at TRUS and disease duration to TRUS was
detected between the groups. Comparing active CD and
UC patients we detected a significantly higher strain
ratio in the group of active CD patients when compared
to active UC patients (median 1.30 vs 0.49; p = 0.0001).
No significant difference in rectal wall thickness was
detected.
Discussion
There are numeorus papers in the current literature on
the issue of EUS elastography. The method was initialy
inaugurated to distinguish te benign from malignant
Table 1 Clinical characteristics of CD and UC patients
CD UC
Number of patients 30 25
Sex - no. of patients (%)
Female 19 (63, 3) 15 (60, 0)
Male 11 (36, 7) 10 (40, 0)
Age at diagnosis (years), median [interquartile range] 23, 01 [18,01-33,27] 33, 35 [23,08-46, 03]
Age at TRUS (years), median [interquartile range] 30, 64 [23,67-42,37] 38, 37 [26,15-53,07]
Disease duration to TRUS (years), median [interquartile range] 5,15[2,02-13,01] 5, 83 [1,82-9,38]
Localization - no. of patients (%)
L1 ± UGI 9 (30)
L2 ± UGI 4 (13, 3)
L3 ± UGI 17 (56, 7)
Rectum involved 14 (46, 7)
Proctitis 3 (12, 0)
Left sided colitis 9 (36, 0)
Pancolitis 13 (52, 0)
Behaviour* - no. of patients (%)
B1 ± perianal 14 (50)
Stricturing ± perianal 9 (32, 1)
Penetrating ± perianal 5 (17, 9)
Perianal (any) 12 (40)
Endoscopy at time of TRUS - no. of patients (%) 24 (80) 25 (100)
Inactive 10 (43, 5)
Mild activity 9 (34, 8)
Severe activity 5 (21, 7)
Baron score 0 11 (11, 8)
Baron score 1 3 (17, 6)
Baron score 2 11 (70, 6)
Baron score 3 0 (0)
* Information about biheviour was available in 28 patients
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Page 3 of 8Figure 1 TRUS elastography in a UC patient. Letter “A” represents first region of interest in mucosal tissue. Letter “B” represents second region
of interest in perirectal tissue.
Figure 2 TRUS elastography in a CD patient. Letter “A” represents first region of interest in mucosal tissue. Letter “B” represents second
region of interest in perirectal tissue.
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biopsy and histological confirmation of cancer, „virtual
biopsy” done by EUS elastography could provide good
information of the consistency of the tissue of interest
[12].
I nt h i ss t u d yw eh y p o t h e s i z e dt h a t„virtual biopsy”
technique might have a good implementation in differ-
entiating colonic tissue in CD and UC [4,13].
Namely, phenotyping of the IBD in clinical practice can
be a very difficult problem. Sometimes the pathological
diagnosis is insufficient or uncertain but also one form of
the disease can change over the years. An adequate phe-
notyping could have a major impact on therapy and
prognosis for the patients. Differentiating UC from
Crohn’s colitis may contribute to inaccurate diagnosis in
up to 30% of IBD patients. The main reason for this
diagnostic uncertainty is overlapping of clinical and his-
tological features [14]. This fact has a great impact in
everyday practice because prolongation in definite diag-
nosis can lead to delay in initiation of appropriate treat-
ment. Different phenotypes require specific diagnostic
and therapeutic solutions [15]. Phenotyping is very
important because of three specific reasons. First,
Crohn’s colitis and UC have different risk of complica-
tions (fistulas, strictures, extraintestinal manifestations)
that require a different therapeutic approach. Second,
regarding to drugs, there is no evidence that mesalazine
is effective in active Crohn’s colitis while quite the con-
trary ulcerative colitis should be treated first with mesala-
zine [16,17]. Delay of introduction of immunosupressives
in misdiagnosed patients with Crohn’s colitis can be dele-
terious. Third, accurate assessment of disease is
Table 2 Summary of results.
IBD Non-IBD controls P value
Age at TRUS, median [IQR], years 33.97 [25.04-46.86] 59.11 [46.51-73.03] 0.0001
Rectal wall thickness, median [IQR] 4, 85 [3.7-5.9] 3.6 [3.1-4.4] 0.001
Strain ratio, median [IQR] 0.82 [0.5-1.23] 0.68 [0.51-0.89] 0.06
Figure 3 Rectal wal thickness in non-IBD controls, CD and UC patients. Box plots indicate 25th and 75th percentile. Medians are
represented by straight lines. Error bars indicate 5th and 95th percentiles.
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of surgical intervention such as proctocolectomy. Specifi-
cally, the formation of ileoanal pelvic reservoir in case of
unrecognized CD is more often complicated by fistula,
stenosis and pelvic sepsis [18].
Biomarkers are increasingly being proposed to
improve phenotyping of patients [19-21]. Unfortunatelly,
in spite of many different new studies on serologic and
genetic markers, there is no satisfactory panel of tests
which can ultimately confirm the diagnosis. Therefore
it’s necessary to search for new diagnostic procedures
that could contribute to more accurate recognition of
t h ed i s e a s ep h e n o t y p ea n di m p r o v ed i a g n o s t i cc o n f i -
dence in IBD. In this sense, EUS elastography could be
an option as a new diagnostic procedure which has the
potential to recognize differences in the UC tissue and
Crohn’s colitis tissue.
In order to define clear differences between the wall of
the colon in CD and UC, our investigation was focused
on the characteristics of the rectal wall and perirectal
tissue, observed by the EUS elastography with SR calcu-
lation. Perirectal tissue in UC patients is supposed to be
soft, without inflammation, and in CD patients „hard
tissue” reflects the transmural nature of inflammation.
T h e s eq u a l i t a t i v ea n dq u a n t i t a t i v ee l a s t o g r a p h yd a t a
could lead to differentiation of IBD phenotypes, and
could help in clinical decision making in patients with
IBD unclassified (IBDU).
In our study we detected a significant difference in
rectal wall thickness when comparing IBD group as a
whole and controls which is in agreement with other
reports from the literature [22,23]. Interestingly, we also
found a significant difference in rectal wall thickness
between CD patients without rectal involvement and
Figure 4 Strain ratio of non-IBD controls, CD and UC patients. Box plots indicate 25th and 75th percentile. Medians are represented by
straight lines. Error bars indicate 5th and 95th percentiles.
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study is unclear but it could suggest a possible predictive
role of TRUS elastography in CD. Bearing in mind the
fact that CD can involve any part of the GI tract it would
be interesting to identify such patients early in the course
of the disease and follow them prospectively to see
whether rectal involvement or perianal disease will
develop. In UC patients a significant difference in rectal
wall thickness but not strain ratio was found between
active UC patients and controls. This finding reflects the
fact that inflammatory process in UC is confined to the
mucosa and submucosa leading to the thickening of the
rectal wall in acute inflammation but without changes in
perirectal tissue as measured by strain ratio. A significant
difference was detected in rectal wall thickness and strain
ratio between CD and UC patient group reflecting the
difference in pathogenetic mechanisms driving these dis-
eases with CD being characterized by transmural inflam-
mation as opposed to UC. Finally, we detected a
significant difference in both rectal wall thickness and
strain ratio between CD patients with rectal involvement
and UC patients with active disease.
According to age, we detected a significant difference
in age at TRUS between IBD group and control group.
However, we believe that this difference did not have
any influence on our results as, to the authors’ knowl-
edge, there are no data in the literature showing that
rectal wall thickness changes with age [24,25]. However,
we believe that the results of our study can be useful in
determining the exact phenotype of IBD. Accurate phe-
notyping is of crucial importance in guiding therapeutic
decisions, especially for planning the type of surgical
procedure. However, currently about 10% of patients
with inflammation restricted to the colon can not be
accurately assessed using standard diagnostic techniques
[26,27]. More important, in 4-6% of UC patients under-
going proctocolectomy with ileoanal pouch formation
CD is subsequently diagnosed with significant morbidity
and high rate of pouch failure [28,29]. Our findings sug-
gest that TRUS elastography might play a role in deter-
mining the phenotype in IBD patients who can not be
classified using standard diagnostic tools. Although we
found a significant difference in rectal wall thickness
and significant difference in strain ratio between CD
patients with rectal involvement and active UC patients
our study is limited with a small number of patients
included. A prospective study with inclusion of a greater
number of patients and ultimately construction of recei-
ver operating characteristics (ROC) curve is needed to
definitely assess the value of TRUS elastography in IBD.
Conclusion
TRUS elastography with strain rato calculation provides
valuable information regarding the stiffness of the rectal
and perirectal tissue and can help to differentiate CD
from UC. According to our results we can conclude that
TRUS elastography could be one of the perspective and
promising diagnostic tools in IBD. A prospective study
on a large cohort of patient is necessary to consolidate
and confirm the results and establish the role of TRUS
in distinguishing Crohn’s colitis and UC. In addition,
one of the important benefits of EUS elastography in
the long run could be the possibility of identifying indi-
viduals at risk of developing a transmural disease,
thereby facilitating appropriate action for prevention of
disease complications.
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